Medulloblastoma in a 38-year-old patient; a case report and literature review

被引:0
作者
Ziolkowska, Ewa [1 ]
Zarzycka, Malgorzata [1 ]
Osmanska-Gogol, Maria [2 ]
机构
[1] Centrum Onkol, Oddzial Radioterapii, Bydgoszcz, Poland
[2] Centrum Onkol, Oddzial Chemioterapii, Bydgoszcz, Poland
来源
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY | 2006年 / 10卷 / 02期
关键词
medulloblastoma; adult; treatment; radiotherapy; chemotherapy;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Medulloblastoma (MB), a malignant neuroectodermal tumour, is rare in adults, accounting for 1% of all primary tumours of the central nervous system. Maximum surgical resection followed by craniospinal irradiation with a posterior fossa boost is the standard treatment. Whether adult MB behaves differently from childhood MB, however, is still not clear, and to date no prospective study of this rare brain tumour has been conducted in adults. Thanks to the progress made in recent years partly due to earlier diagnoses and improvements in operative techniques, craniospinal radiotherapy including mega voltage radiation therapy equipment and the inclusion of the spinal neuro-axis within the treatment field, as well as the administration of adjuvant chemotherapy in high-risk patients, long-term survival is now possible, with the overall survival rate ranging from 50-60% at 5 years and 40-50% at 10 years. At present, chemotherapy is not yet uniformly accepted as a standard treatment for patients with the best prognostic factors. Based on the assumption that the disease pattern in adults is similar to that in children, adults with medulloblastoma are treated using paediatric protocols. We report the case history of a 38-year-old man with medulloblastoma. A subtotal tumour resection, adjuvant craniospinal RT with chemotherapy at the same time and after were performed. The period from the diagnosis to this day is 6 years. This patient is in a good condition without relapse in NMR and late side-effects.
引用
收藏
页码:72 / 76
页数:5
相关论文
共 25 条
[1]   Medulloblastoma in adults: Treatment results and prognostic factors [J].
Abacioglu, U ;
Uzel, O ;
Sengoz, M ;
Turkan, S ;
Ober, A .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (03) :855-860
[2]  
Biernat W., 2001, POL J PATHOL, V53, P125
[3]   MEDULLOBLASTOMA IN ADULTS - A REVIEW OF 47 PATIENTS TREATED BETWEEN 1952 AND 1981 [J].
BLOOM, HJG ;
BESSELL, EM .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1990, 18 (04) :763-772
[4]   Review of the prognostic factors in medulloblastoma of children and adults [J].
Brandes, AA ;
Paris, MK .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2004, 50 (02) :121-128
[5]   The treatment of adults with medulloblastoma: A prospective study [J].
Brandes, AA ;
Ermani, M ;
Amista, P ;
Basso, U ;
Vastola, F ;
Gardiman, M ;
Iuzzolino, P ;
Turazzi, S ;
Rotilio, A ;
Volpin, L ;
Mazza, C ;
Sainati, L ;
Ammannati, F ;
Berti, F .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (03) :755-761
[6]   Medulloblastoma in adults: clinical characteristics and treatment [J].
Brandes, AA ;
Palmisano, V ;
Monfardini, S .
CANCER TREATMENT REVIEWS, 1999, 25 (01) :3-12
[7]   Adult medulloblastoma: Prognostic factors and patterns of relapse [J].
Chan, AW ;
Tarbell, NJ ;
Black, PM ;
Louis, DN ;
Frosch, MP ;
Ancukiewicz, M ;
Chapman, P ;
Loeffler, JS .
NEUROSURGERY, 2000, 47 (03) :623-631
[8]   Results of a prospective randomized trial comparing standard dose neuraxis irradiation (3,600cGy/2O) with reduced neuraxis irradiation (2,340cGy/13) in patients with low-stage medulloblastoma - A combined Children's Cancer Group Pediatric Oncology Group Study [J].
Deutsch, M ;
Thomas, PRM ;
Krischer, J ;
Boyett, JM ;
Albright, L ;
Aronin, P ;
Langston, J ;
Allen, JC ;
Packer, RJ ;
Linggood, R ;
Mulhern, R ;
Stanley, P ;
Stehbens, JA ;
Duffner, P ;
Kun, L ;
Rorke, L ;
Cherlow, J ;
Freidman, H ;
Finlay, JL ;
Vietti, T .
PEDIATRIC NEUROSURGERY, 1996, 24 (04) :167-176
[9]   What's new in neuro-oncology? Recent advances in medulloblastoma [J].
Ellison, DW ;
Clifford, SC ;
Gajjar, A ;
Gilbertson, RJ .
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2003, 7 (02) :53-66
[10]   THE TREATMENT OF MEDULLOBLASTOMA - RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL OF RADIATION-THERAPY WITH AND WITHOUT CCNU, VINCRISTINE, AND PREDNISONE [J].
EVANS, AE ;
JENKIN, RDT ;
SPOSTO, R ;
ORTEGA, JA ;
WILSON, CB ;
WARA, W ;
ERTEL, IJ ;
KRAMER, S ;
CHANG, CH ;
LEIKIN, SL ;
HAMMOND, GD .
JOURNAL OF NEUROSURGERY, 1990, 72 (04) :572-582